Laddar...
Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
Pancreatic cancer is a highly aggressive and deadly disease harboring a distinct population of cancer stem cells (CSC) that is not affected by conventional therapies. A new therapeutic approach using the EpCAM/CD3-bispecific antibody MT110 is capable of activating and redirecting cytotoxic T cells t...
Sparad:
Huvudupphovsmän: | , |
---|---|
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
Landes Bioscience
2012
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382890/ https://ncbi.nlm.nih.gov/pubmed/22754787 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|